Y-mAbs Therapeutics (YMAB) Stock Soars On SERB’s Takeover Offer

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) witnessed a sharp surge in its share price on Tuesday after confirming a definitive acquisition deal with SERB Pharmaceuticals. YMAB stock jumped 103.34%, closing at $8.52. SERB to Acquire Y-mAbs and Lead Oncology Asset The agreement states that SERB would buy Y-mAbs for $8.60 per share, which is 105% more […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.